Clinical efficacy of regimens in patients with anaplastic lymphoma kinase fusion gene-positive pulmonary adenocarcinoma of acquired crizotinib resistance

WU Biao; ZHUANG Wu; HUANG Cheng; ZHENG Xiaobin; YIN Yi; ZHANG Jing; JIANG Kan; MIAO Qian

doi:10.3969/j.issn.1009-0460.2018.08.009

Home>Articles>Clinical efficacy of regimens in patients with anaplastic lymphoma kinase fusion gene-positive pulmonary adenocarcinoma of acquired crizotinib resistance

DOI: 10.3969/j.issn.1009-0460.2018.08.009

Clinical efficacy of regimens in patients with anaplastic lymphoma kinase fusion gene-positive pulmonary adenocarcinoma of acquired crizotinib resistance

WU Biao

ZHUANG Wu

HUANG Cheng

ZHENG Xiaobin

YIN Yi

ZHANG Jing

JIANG Kan

MIAO Qian

Machine-generated Keywords：

Publication Date：2018-08-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 716-720 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2018,23(8)